InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Royan Ajay, 董事. Officer active across 2 companies, notably Adagio Therapeutics, Inc.. Aggregated, 3 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €21k. Activity tracked since 14 March 2025. The latest transaction was filed on 14 March 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Ajay Royan is a Board Member at Adagio Therapeutics, Inc. He plays a key role in the governance of the company, contributing to strategy and oversight of operations. His expertise in biotechnology is valuable for the development of Adagio.